About Junic Pharmaceuticals

 Junic Pharmaceuticals became part of the Junic Group in early 2018. It was set up to address the significant gaps in availability of medications useful for improving the reproductive health of women in developing countries.   The company is currently working to introduce an intrauterine adhesion prevention drug for managing Asherman’s Syndrome in sub Saharan Africa